9. Therapeutic Apheresis in Hematologic Disorders: Its indication and evaluation
نویسندگان
چکیده
منابع مشابه
Therapeutic apheresis for renal disorders.
This review summarizes the clinical evidence and practical details for the use of plasmapheresis and other apheresis modalities for each indication in nephrology. Updated information on the molecular biology and immunology of each renal disease is discussed in relation to the rationale for apheresis therapy and its place amid other available treatments. Autoantibody-mediated diseases, such as a...
متن کاملPharmacological and computational evaluation of Sapodilla and its constituents for therapeutic potential in hyperactive gastrointestinal disorders
Objective(s): This study was designed to investigate various gastrointestinal effects of Manilkara zapota (Sapodilla), exploring its anti-diarrheal, anti-secretary, anti-spasmodic, anti-ulcer and anti-motility potential.Materials and Methods: Antidiarrheal and anti-secretary activities were investigated using castor oil induced diarrhea ...
متن کاملTherapeutic apheresis in peripheral and retinal circulatory disorders
In microcirculation disorders, the therapeutic apheresis seems to have two different effects. The first, achieved after only a few sessions, is acute, consisting of drastic reduction of blood viscosity and obtained with the use of low-density lipoprotein (LDL) apheresis, rheopheresis, or fibrinogen apheresis. The second effect is long term, or chronic, and needs to be evaluated after a long cou...
متن کاملTherapeutic Apheresis
1 apheresis . The advent of sophisticated blood cell separators (Figure 1) has dramatically changed the application of apheresis with increasingly specific blood cells being targeted. This technology is now used in both the donor setting for the collection of blood product and in the therapeutic application for the treatment of many disease processes. The technique of apheresis has been develop...
متن کاملTherapeutic Apheresis in Dyslipidemia
In the last decades, LDL apheresis was introduced as an extracorporeal treatment option for patients with homozygous or severe heterozygous familial hypercholesterolemia. The prognosis of patients suffering from severe dyslipidemia, sometimes combined with elevated lipoprotein (a) levels, and coronary heart disease refractory to diet and lipid-lowering drugs is poor. For such patients, regular ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Medicine
سال: 1986
ISSN: 0021-5120,1881-123X
DOI: 10.2169/internalmedicine1962.25.215